Naira
I dont disagree with you and we have been disappointed in the past and this might occur again. However, if GSK doesnt disappoint and gives a good outlook for Relenza the shares could surge. Therefore, not buying is essentially a bet that GSK will disappoint tonight. On the basis of the available evidence I think this is a pretty big bet to make. But who really knows in the world of biotechs.....
